Honey, propolis, royal jelly, pollen and bee venom each carry genuinely bioactive compounds — but "natural" is not a safety guarantee, and traditional use is not the same as clinical proof. This lab visualises the idea that runs through the article: every remedy has a dose-response curve, a point where more stops helping, and — for some products — a real allergy or anaphylaxis risk that gets worse with sensitisation, not better.
Bee venom has by far the narrowest safe window of the five: the same compounds under study for anti-inflammatory effects (melittin, apamin) are also exactly what triggers anaphylaxis in venom-allergic people, which is why any venom-based therapy needs medical supervision, not self-experimentation.
A 3D dose-response lab where a glowing honeycomb streams particles of your chosen bee product toward a body figure, while a live floating graph shows the point where benefit plateaus and risk climbs.
Every remedy — honey, propolis, royal jelly, pollen, venom — has its own safe dose window and risk slope. The simulation turns that abstract idea into a visible curve, a colour-coded safety zone, and a body aura that shifts from teal to warning red as you push past it.
Pick a product, drag the dose slider, and raise personal sensitivity to see how allergy-prone individuals hit trouble sooner. Toggle raw vs. heated/processed to see heat-sensitive bioactives lose potency, most notably in honey's natural enzymes.
Bee venom has by far the narrowest safety margin of the five products: the same peptides being studied for anti-inflammatory effects are exactly what triggers anaphylaxis in venom-allergic people.